CNS Pharmaceuticals CNSP 深 滬
等待開盤 02-10 09:30:00 美东时间
4.27
-0.240
-5.32%
華盛通- 最 高4.4818
- 今 開4.41
- 成交量 3.11万股
- 最 低 4.26
- 昨 收 4.51
- 總市值 264.86万
- 52周最高 55.20
- 市盈率 靜 --
- 換手率 5.02%
- 52周最低 4.26
- 委 比 48.19%
- 總股本 62.03万
- 歷史最高 5121000.00
- 量 比 1.83
- 振 幅 4.92%
- 歷史最低 4.26
- 每 手 1
- 風險率 12.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation
CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation CNS Pharmaceuticals Inc. has announced a strategic plan focused on transforming its operations to create long-term value for shareholders. The newly appointed Pre
01-27 22:51
CNS Pharmaceuticals Announces New CEO Appointment
The latest announcement is out from CNS Pharmaceuticals ( ($CNSP) ). On Decembe...
2025-12-17 21:58
CNS Pharmaceuticals CEO John Climaco Steps Down, Rami Levin Named New Chief Executive
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous
2025-12-17 20:08
CNS Pharmaceuticals Increases Authorized Shares for Growth
CNS Pharmaceuticals ( ($CNSP) ) just unveiled an update. On November 17, 2025, ...
2025-11-22 06:51
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
Cns Pharmaceuticals, Inc. ( ($CNSP) ) has released its Q3 earnings. Here is a b...
2025-11-18 12:00
Belgium purchases kamikaze drones to protect air space
Belgium plans to acquire loitering munitions from a Latvian manufacturer as it responds to a wave of mysterious drone incursions that have briefly shut down airports, disrupted military facilities and...
2025-11-18 02:25
CNS Pharmaceuticals Q3 EPS $(5.76) Beats $(7.09) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(5.76) per share which beat the analyst consensus estimate of $(7.09) by 18.82 percent. This is a 96.24 percent increase over losses of $(153.20) per share
2025-11-17 22:43
Avadel Pharmaceuticals Settles Lawsuits with Jazz Pharmaceuticals
Avadel Pharmaceuticals ( ($AVDL) ) has shared an announcement. On October 21, 2...
2025-10-22 18:58
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
2025-09-15 11:13
Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target
Maxim Group analyst Jason McCarthy upgrades CNS Pharma (NASDAQ:CNSP) from Hold to Buy and announces $20 price target.
2025-09-12 22:08
